Peking University Weifang Birth Cohort
Official title: Peking University Birth Cohort in Weifang
Run by Peking University · NCT06234332 · Data updated 2026-11-12
This project will follow pregnant women in Weifang and their children to see if pre-pregnancy and prenatal exposures affect maternal and child health up to age 18.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2800 (estimated) |
| Sponsor | Peking University Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | February 1, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2043 |
| Registry record updated | November 24, 2025 |
| Trial ID | NCT06234332 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Pregnant women at about 6–13+6 weeks who have lived in Weifang for at least six months, plan antenatal care and delivery at Weifang Maternal & Child Hospital, and their willing husbands and future children are ideal candidates.
✕Probably not a fit
People who live outside Weifang, plan to move away, cannot communicate normally, or expect immediate treatment changes from participation are unlikely to receive direct clinical benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective birth cohort enrolling pregnant women early in pregnancy in Weifang, China, with follow-up of mothers, fathers, and children from birth through childhood. Investigators collect detailed information on environmental, nutritional, and lifestyle exposures and record short- and long-term health outcomes. Multiple biological samples (blood, urine, placenta, cord blood, umbilical cord, and feces) are banked for future biomarker and mechanistic studies. Data linkage and repeated follow-up visits will allow study of how exposures before and during pregnancy relate to outcomes such as gestational diabetes, hypertension, and preterm birth and later child health.
Why it matters
Potential benefit: If successful, the findings could help clinicians and public health programs prevent or reduce pregnancy complications and long-term health problems in mothers and children.
How similar studies have gone: Other large birth cohorts have successfully linked prenatal exposures to childhood and adult health outcomes, so this cohort follows an established, productive approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant woman 1. Pregnant women, 6-13\^+6 gestational weeks 2. Resided in Weifang in the past half years and have no plan to move out after delivery 3. Pregnant women who plan to have antenatal care and delivery in Weifang maternal\&Child Hospital. 4. Pregnant women who is willing to participate in this study with informed consent * Pregnant woman's husband 1. His wife was eligible for enrollment 2. He is the biological father of the child (his wife's current pregnancy) 3. Pregnant women's husband who is willing to participate in this study with informed consent * Offspring 4. Children born to pregnant women who met the inclusion criteria after enrolling in this study. 5\. Before the age of 8 years, his/her mother provided written informed consent. 6. After 8 years old, he/she agreed to continue this study and signed the informed consent. Exclusion Criteria: * Participants who cannot communicate normally.
Where it's running
-
Peking University
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Principal investigator: Haijun Wang, Ph.D — Peking University
- Study coordinator: Haijun Wang, Ph.D
- Email: whjun1@bjmu.edu.cn
- Phone: 86-010-82805583
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
DISC-0974-201 for adults with IBD-related anemia
This Phase 2 trial will test whether DISC-0974-201 helps adults with inflammatory bowel disease who have anemia driven by inflammation.
-
Preoperative IV ferric derisomaltose to prevent anemia and improve quality of life in obese patients having bariatric surgery
This trial tests whether a single preoperative IV ferric derisomaltose dose, compared with saline placebo, prevents postoperative anemia and improves quality of life for iron-deficient obese patients undergoing bariatric surgery.
-
National registry for people with myelofibrosis and anemia in Germany.
This project will collect health, treatment, and quality-of-life information from people in Germany with primary or secondary myelofibrosis and anemia to see how their care and symptoms change over time.
-
Delivering HOPE: healthy food and grocery support during pregnancy
This project will test whether providing pregnant people with healthy food and grocery funds during pregnancy reduces excessive weight gain compared with enhanced usual care.
-
Understanding how growth hormone affects insulin-producing cells in women with gestational diabetes
This study looks at how growth hormone affects insulin-producing cells in women who had gestational diabetes compared to those who didn't, to see if it helps us understand their risk for type 2 diabetes.
-
Examining how diet and nutrition affect growth and development in young children
This study looks at how the diets of young children in rural areas of Pakistan affect their growth and development compared to children from urban areas.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.